Here’s everything you need to know about the latest Google Gemini 2.0 update, including new AI models like Flash, Pro, and ...

Companies in this age now invest a significant amount of resources in research and development with the goal of developing ecosystems that are capable of making complicated technologies appear to be ...

Vertex's expansion into these high-need areas is expected to diversify its revenue streams further and strengthen its market position. JesterAI is a Foolish AI, based on a variety of Large ...

Vertex is faced with an access challenge as it is charging $15.50 for a 50 mg dose of Journavx, which works out to $420 for a two-week course. Generic opioids, meanwhile, go for roughly $0.50 a pill.

Vertex Pharmaceuticals beat expectations for revenue but missed on earnings. The company has two recent FDA approvals and several treatments in late-stage trials. The core CF treatments make up ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

From data center cooling to novel chip design, VCs are pouring cash into startups making AI more cost-efficient and ...

founding members of the Summit have launched Public Interest AI Platform and Incubator to bridge gaps between public and private efforts, and reduce digital divides. A joint statement titled ...

AI Agent is an autonomous intelligent system ... Creating a Knowledge Base in Copilot Studio Agent Builder is easier than the Vertex Agent Builder platform. To create a Knowledge Base, click ...

After testing the various models in Google's new Gemini 2.0 family, something interesting becomes clear: Google is exploring the potential of specialized AI systems working in concert similar to ...